Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 36
2023 66
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Post-Exposure Prophylaxis for COVID-19: A Systematic Review.
SeyedAlinaghi S, Karimi A, Pashaei Z, Shobeiri P, Janfaza N, Behnezhad F, Ghasemzadeh A, Barzegary A, Arjmand G, Noroozi A, Shojaei A, Amiri A, Vahedi F, Mahalleh M, Shamsabadi A, Dashti M, Afsahi AM, Mehraeen E, Dadras O. SeyedAlinaghi S, et al. Infect Disord Drug Targets. 2023;23(5):e130423215723. doi: 10.2174/1871526523666230413082721. Infect Disord Drug Targets. 2023. PMID: 37069717
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
Levin MJ, Ustianowski A, Thomas S, Templeton A, Yuan Y, Seegobin S, Houlihan CF, Menendez-Perez I, Pollett S, Arends RH, Beavon R, Dey K, Garbes P, Kelly EJ, Koh GCKW, Ivanov S, Near KA, Sharbaugh A, Streicher K, Pangalos MN, Esser MT; COVID-19 Study to Optimally Reduce Morbidity in CareHomes and Sites with Enhanced Risk (STORMCHASER) Study Group. Levin MJ, et al. Clin Infect Dis. 2023 Apr 3;76(7):1247-1256. doi: 10.1093/cid/ciac899. Clin Infect Dis. 2023. PMID: 36411267 Free PMC article. Clinical Trial.
Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.
Song R, Zeng G, Yu J, Meng X, Chen X, Li J, Xie X, Lian X, Zhang Z, Cao Y, Yin W, Jin R. Song R, et al. Emerg Microbes Infect. 2023 Dec;12(1):2212806. doi: 10.1080/22221751.2023.2212806. Emerg Microbes Infect. 2023. PMID: 37157134 Free PMC article. Clinical Trial.
114 results